Startups
Massachusetts Eye and Ear is a specialty hospital dedicated to excellence in the care of disorders that affect the eye, ear, nose, throat, and adjacent regions of the head and neck. Mass Eye and Ear provides primary care and serves as a referral center for outpatient and inpatient medical and surgical care.
In conjunction with Harvard Medical School, Mass Eye and Ear is committed to the education of future health care professionals, as well as the education of the public concerning the prevention, diagnosis, and treatment of the diseases in its specialties and concerning the rehabilitation of patients handicapped by these diseases.
In order to provide the highest quality of contemporary care and even better care in the future, Mass Eye and Ear conducts laboratory and clinical research in its areas of specialty.
Mass Eye and Ear recognizes its obligation to serve as a source of excellence in patient care, teaching, and research in Massachusetts, the United States, and the world.
Interested in joining the Mass Eye and Ear team? Visit https://masseyeandear.org/careers.
In conjunction with Harvard Medical School, Mass Eye and Ear is committed to the education of future health care professionals, as well as the education of the public concerning the prevention, diagnosis, and treatment of the diseases in its specialties and concerning the rehabilitation of patients handicapped by these diseases.
In order to provide the highest quality of contemporary care and even better care in the future, Mass Eye and Ear conducts laboratory and clinical research in its areas of specialty.
Mass Eye and Ear recognizes its obligation to serve as a source of excellence in patient care, teaching, and research in Massachusetts, the United States, and the world.
Interested in joining the Mass Eye and Ear team? Visit https://masseyeandear.org/careers.
Overview
Location
United States, Massachusetts, Boston
Employees
1001-5000
Phone
+1 617-523-7900
Total raised
$31K
Founded date
1824
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 26
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 23, 2026 | GelMEDIX Secures $13 Million to Advance Vision Restoration | GelMEDIX, a biotechnology innovator, closed a $13 million seed funding round. Safar Partners spearheaded the investment. This capital fuels the company's lead program, GMX-101. GMX-101 targets late-stage Geographic Atrophy, a devastating fo... |
| Feb 17, 2026 | GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform | GelMEDIX, a biotechnology company developing regenerative therapies to restore vision, has completed a $13 million seed financing round led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Boston Angels, Bost... |
| Feb 17, 2026 | GelMEDIX Raises $13M in Seed Funding | GelMEDIX, a Cambridge, MA-based biotechnology company developing regenerative therapies to restore vision, raised $13M in Seed funding. The round was led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Bosto... |
| Nov 6, 2024 | SightMD New Jersey Welcomes Marez Megalla, MD to its expert team | SightMD New Jersey SightMD NJ, a leading multi-specialty ophthalmology platform in New Jersey, welcomes Marez Megalla, MD to its expert team. HAUPPAUGE, N.Y., Nov. 6, 2024 /PRNewswire-PRWeb/ -- SightMD NJ, a leading multi-specialty ophthalm... |
| Oct 17, 2024 | New "Prevalence of Glaucoma Among US Adults in 2022" Study Finds Higher Prevalence of the Eye Disease Than Previously Estimated | New "Prevalence of Glaucoma Among US Adults in 2022” study estimates glaucoma and vision-affecting glaucoma prevalence by demographic factors, and by U.S. state and county. New research study estimates glaucoma and vision-affecting gla... |
| Jul 9, 2024 | «Оземпик» может вызывать слепоту — исследование | Гарвардские ученые обнаружили: у пациентов, который был назначен семаглутид, в четыре-семь раз чаще развивалась неартериитная передняя ишемическая нейропатия зрительного нерва, чем у принимавших другие препараты для снижения веса. Семаглути... |
| Jun 6, 2024 | In a First, Gene Therapy Restores Hearing in Both Ears of 5 Children Born Deaf | By Inno Flores Published Jun 6, 2024 4:17AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard Share on Pocket A groundbreaking gene therapy has successfully restored hearing in both ears of five chi... |
| May 6, 2024 | CRISPR Gene Editing Shows Promise: Early Trial Improves Vision in Blind Children | Quincy Jon, Tech Times 06 May 2024, 07:05 pm An early-stage clinical experiment published in the New England Journal of Medicine found that gene therapy can improve hereditary blindness. Researchers from the Children's Hospital of Philadelp... |
| Mar 17, 2023 | Sleep Loss Robs Your Health And Wealth | Enjoy your extra hour of sleep this week, because most Americans switch to Daylight Savings Time Monday and will have to get up one hour earlier. However, sleep loss is a year-round problem that affects everything from your health to your w... |
Show more
Reviews 0
FAQ about Mass Eye and Ear
When was Mass Eye and Ear founded?
Mass Eye and Ear was founded in 1824.
How much funding has Mass Eye and Ear raised?
Mass Eye and Ear has raised $31K in total across 1 funding round.
What has the press written about Mass Eye and Ear?
Parsers VC has collected 26 articles mentioning Mass Eye and Ear, among them “GelMEDIX Secures $13 Million to Advance Vision Restoration” (Feb 23, 2026) and “GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform” (Feb 17, 2026).
Is Mass Eye and Ear still active?
Yes, Mass Eye and Ear is active; its latest activity on Parsers VC dates from Jun 10, 2026.